Dosage and administration
DIRECTIONS: TAKE 2 PUMP SPRAYS 3 TIMES DAILY. HOLD UNDER TONGUE 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGEWS 12 TO ADULT.
DIRECTIONS: TAKE 2 PUMP SPRAYS 3 TIMES DAILY. HOLD UNDER TONGUE 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGEWS 12 TO ADULT.
Cholesterium 18X,36X,LM2
Damiana 18X,36X,LM2
DNA 18X, 36X,LM2
Hypothalamus 12X,30X,LM1
Lechithinum 12X,30X,LM1
Phosphoricum acidum 12X,30X,LM1
Sabal 12X,30X,LM1
KEEP OUT OF REACH OF CHILDREN
FOR BOTH MALE AND FEMALE conditions including fatigue, loss of libido, impotence, premature ejaculation supports the balance of the male hormonal system, including the production and release of sperm, prostate afflictions and exhaustion after coition
DIRECTIONS: TAKE 2 PUMP SPRAYS 3 TIMES DAILY. HOLD UNDER TONGUE 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGEWS 12 TO ADULT.
For the temporary relief of FOR BOTH MALE AND FEMALE conditions including fatigue, loss of libido, impotence, premature ejaculation supports the balance of the male hormonal system, including the production and release of sperm, prostate afflictions and exhaustion after coition
WARNING: STOP USE AND CALL DOCROR if symptoms persist or worsen.
Other information: Tamper resistant for your protection. Use only if safety seal is intact
If pregnant or breast-feeding consult a healthcare professional before use
POTASSIUM SORBATE 0.1%
CITRIC ACID 0.0075%
Purified water
MANUFACTURED FOR
MICRO-WEST
P.O. Box 950
DOUGLAS ,WY 82633
1-307-358-5066
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61657-0970-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-73c6-f424-e053-dadaa90a57ce | DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61657-0970-1 | TOTAL ANDRO-BAL | 30 mL in 1 BOTTLE, PUMP | LIQUID | 30 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61657-0970 | TOTAL ANDRO-BAL (DAMIANA, LECITHINUM,PHOSPHORICUM ACIDUM,SABAL SERRATA, CHOSESTERINUM,DNA,HYPOTHALAMUS,ADRENAL CORTEX, DHEA,PREGNENOLONE,PROGESTERONE,TESTOSTERONE) LIQUID [WHITE MANUFACTURING INC. DBA MICRO WEST] | 4 | Legacy NDC, 1 package rows | 20140814_8b3af556-74fb-4054-80ca-2a973a9bc617.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 4 | |
| CHOLESTEROL | ACTIVE INGREDIENT | 97C5T2UQ7J | 4 | |
| EGG PHOSPHOLIPIDS | ACTIVE INGREDIENT | 1Z74184RGV | 4 | |
| HERRING SPERM DNA | ACTIVE INGREDIENT | 51FI676N6F | 4 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 4 | |
| PRASTERONE | ACTIVE INGREDIENT | 459AG36T1B | 4 | |
| PREGNENOLONE | ACTIVE INGREDIENT | 73R90F7MQ8 | 4 | |
| PROGESTERONE | ACTIVE INGREDIENT | 4G7DS2Q64Y | 4 | |
| SAW PALMETTO | ACTIVE INGREDIENT | J7WWH9M8QS | 4 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 4 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 4 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE INGREDIENT | RQ2CFA7WWJ | 4 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 4 | |
| CHOLESTEROL | ACTIVE MOIETY | 97C5T2UQ7J | 4 | |
| EGG PHOSPHOLIPIDS | ACTIVE MOIETY | 1Z74184RGV | 4 | |
| HERRING SPERM DNA | ACTIVE MOIETY | 51FI676N6F | 4 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 4 | |
| PRASTERONE | ACTIVE MOIETY | 459AG36T1B | 4 | |
| PREGNENOLONE | ACTIVE MOIETY | 73R90F7MQ8 | 4 | |
| PROGESTERONE | ACTIVE MOIETY | 4G7DS2Q64Y | 4 | |
| SAW PALMETTO | ACTIVE MOIETY | J7WWH9M8QS | 4 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 4 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 4 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE MOIETY | RQ2CFA7WWJ | 4 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 4 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61657-0970 | 61657-0970-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TURNERA DIFFUSA LEAFY TWIG | RQ2CFA7WWJ | ACTIB |
| EGG PHOSPHOLIPIDS | 1Z74184RGV | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| SAW PALMETTO | J7WWH9M8QS | ACTIB |
| CHOLESTEROL | 97C5T2UQ7J | ACTIB |
| HERRING SPERM DNA | 51FI676N6F | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| PRASTERONE | 459AG36T1B | ACTIB |
| PREGNENOLONE | 73R90F7MQ8 | ACTIB |
| PROGESTERONE | 4G7DS2Q64Y | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| aa6655d5-6e99-4f6b-b317-1bcb158d02b3 | 8b3af556-74fb-4054-80ca-2a973a9bc617 | 2014-08-12 | Warnings | aa6655d5-6e99-4f6b-b317-1bcb158d02b3 8b3af556-74fb-4054-80ca-2a973a9bc617 |
Adverse event summaries are temporarily unavailable. Other product information remains available.